VIVORYON THERAPEUTIC

VVY
Real-time Euronext Amsterdam - 11:35 2022-12-01 am EST
10.10 EUR +1.30%

Turn to zoom
Prev.10.10000000
Open9.98000000
High10.40000000
Low9.80000000
Volume69 660
Latest news
3d ago
11/23
11/22
11/22
Chart VIVORYON THERAPEUTICS N.V.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBearish
Resistance10,310,311,9
Spread/Res.-2,1%-2,1%-15%
Spread/Supp.23%23%45%
Support8,218,216,98
Financials
Sales 2022 - - -
Net income 2022 -12,1 M -12,5 M -12,5 M
Net cash 2022 41,3 M 42,6 M 42,6 M
P/E ratio 2022 -18,1x
Yield 2022 -
Capitalization 240 M 248 M 248 M
EV / Sales 2022 -
EV / Sales 2023 -
Nbr of Employees 15
Free-Float 72,7%
Company
Vivoryon Therapeutics N.V. (formerly Vivoryon Therapeutics AG) specializes in the research and development of therapeutic products for the treatment of Alzheimer disease.
At the end of 2021, the group has a portfolio of a product in phase II clinical development (PQ912) and 2 products in the...
Sector :
Other Biotechnology & Medical Research
Calendar :
2023-01-09 Presentation

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 9,97 €
Average target price 60,00 €
Spread / Average Target 502%